NUTRIBAND INC. (NTRB) Operating Margin
- Operating margin · 12 months: Value -435.58%; Formula and calculation Operating income / revenue. Period ending 2026-07-31..
Operating margin
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -435.58% | Operating income / revenue. Period ending 2026-07-31. $-7.05M ÷ $1.62M × 100 ≈ -435.58% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -7.05M USD | Operating Income (Loss) |
| Revenue | 1.62M USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 1.21M USD | Research and Development Expense |
| Selling, general and administration | 6.37M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-31 | $-7.05M | $1.62M | (m) | $1.21M | $6.37M | -435.58% |
| 2026-04-30 | $-8.16M | $1.80M | (m) | $1.45M | $7.21M | -452.61% |
| 2026-01-31 | $-8.32M | $2.04M | (m) | $1.89M | $6.99M | -408.41% |
| 2025-10-31 | $-12.86M | $2.28M | (m) | $2.19M | $7.83M | -564.27% |
| 2025-07-31 | $-10.40M | $2.58M | (m) | $2.62M | $5.08M | -403.49% |
| 2025-04-30 | $-9.81M | $2.40M | (m) | $2.83M | $4.22M | -408.97% |
| 2025-01-31 | $-10.28M | $2.14M | (m) | $3.12M | $4.31M | -480.70% |
| 2024-10-31 | $-6.03M | $2.02M | (m) | $3.19M | $3.48M | -298.37% |
| 2024-07-31 | $-6.33M | $1.80M | (m) | $2.86M | $4.07M | -350.87% |
| 2024-04-30 | $-5.74M | $2.02M | (m) | $2.53M | $4.01M | -284.77% |
| 2024-01-31 | $-4.87M | $2.09M | $1.92M | $1.96M | $3.77M | -233.63% |
| 2023-10-31 | $-5.25M | $2.09M | $1.86M | $1.69M | $4.04M | -251.37% |
| 2023-07-31 | $-4.60M | $2.28M | $1.96M | $1.43M | $3.76M | -201.77% |
| 2023-04-30 | $-4.81M | $2.08M | $1.78M | $1.26M | $3.99M | -231.27% |
| 2023-01-31 | $-4.48M | $2.08M | $1.79M | $982.23K | $3.92M | -215.19% |
| 2022-10-31 | $-6.57M | $2.04M | (m) | (m) | $4.26M | -321.27% |
| 2022-07-31 | $-7.03M | $1.71M | (m) | (m) | $4.66M | -411.57% |
| 2022-04-30 | $-6.48M | $1.47M | (m) | (m) | $4.24M | -442.02% |
| 2022-01-31 | $-6.11M | $1.42M | (m) | $411.38K | $4.02M | -429.68% |
| 2021-10-31 | $-4.52M | $768.14K | (m) | (m) | $4.94M | -588.09% |
| 2021-07-31 | $-3.02M | $876.90K | (m) | (m) | $3.66M | -344.38% |
| 2021-04-30 | $-2.76M | $747.61K | (m) | (m) | $3.34M | -369.63% |
| 2021-01-31 | $-2.60M | $943.70K | (m) | (m) | $2.96M | -275.08% |
| 2020-10-31 | $-1.03M | $615.19K | (m) | (m) | $1.10M | -167.49% |
| 2020-07-31 | $-1.32M | $305.96K | (m) | (m) | $1.20M | -431.42% |
| 2020-04-30 | $-1.54M | $296.42K | (m) | (m) | $1.41M | -520.80% |
| 2020-01-31 | $-1.97M | $370.65K | (m) | (m) | $1.79M | -531.35% |
| 2019-10-31 | (m) | $433.54K | (m) | (m) | $1.80M | (m) |
| 2019-07-31 | (m) | $513.79K | (m) | (m) | $1.94M | (m) |
| 2019-04-30 | (m) | (m) | (m) | (m) | $3.41M | (m) |
| 2019-01-31 | (m) | $245.28K | (m) | (m) | $3.29M | (m) |
| 2018-10-31 | (m) | (m) | (m) | (m) | $976.21K | (m) |
| 2018-07-31 | $-4.87M | (m) | (m) | (m) | $2.37M | (m) |
| 2018-04-30 | $-3.08M | (m) | (m) | (m) | $584.43K | (m) |
| 2018-01-31 | $-2.67M | (m) | (m) | (m) | $171.95K | (m) |
| 2017-10-31 | $-269.89K | (m) | (m) | (m) | $269.89K | (m) |
| 2017-07-31 | $-192.13K | (m) | (m) | (m) | $192.13K | (m) |
| 2017-04-30 | $-134.80K | (m) | (m) | (m) | $134.80K | (m) |
| 2017-01-31 | $-151.26K | (m) | (m) | (m) | $151.26K | (m) |
| 2016-10-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-04-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-01-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |